In 1981, the DEA submitted a see of intention to position ketamine in Program III from the Managed Substances Act, but proof of real abuse was scarce and didn't aid the designation. Clinics may perhaps present it in oral kind, as a nasal spray, or by intravenous or intramuscular injection, https://ketalinic.com/about-us/